Arbutus Biopharma Corp. (ABUS)
4.115
-0.04
(-0.84%)
USD |
NASDAQ |
Oct 13, 16:00
4.12
0.00 (0.00%)
After-Hours: 16:38
Arbutus Biopharma Free Cash Flow (Quarterly) : -5.952M for June 30, 2026
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -5.952M |
| March 31, 2026 | -8.11M |
| December 31, 2025 | -4.226M |
| September 30, 2025 | -5.840M |
| June 30, 2025 | -16.26M |
| March 31, 2025 | -13.39M |
| December 31, 2024 | -9.219M |
| September 30, 2024 | -20.76M |
| June 30, 2024 | -14.27M |
| March 31, 2024 | -19.39M |
| December 31, 2023 | -16.21M |
| September 30, 2023 | -21.94M |
| June 30, 2023 | -20.59M |
| March 31, 2023 | -27.42M |
| December 31, 2022 | -15.98M |
| September 30, 2022 | -18.45M |
| June 30, 2022 | -20.51M |
| March 31, 2022 | 20.54M |
| December 31, 2021 | -19.51M |
| September 30, 2021 | -15.33M |
| June 30, 2021 | -15.15M |
| March 31, 2021 | -17.98M |
| December 31, 2020 | -16.19M |
| September 30, 2020 | -13.03M |
| June 30, 2020 | -8.512M |
| Date | Value |
|---|---|
| March 31, 2020 | -15.45M |
| December 31, 2019 | -13.35M |
| September 30, 2019 | -24.27M |
| June 30, 2019 | -17.74M |
| March 31, 2019 | -16.61M |
| December 31, 2018 | -16.82M |
| September 30, 2018 | -13.03M |
| June 30, 2018 | -17.66M |
| March 31, 2018 | -20.22M |
| December 31, 2017 | -9.672M |
| September 30, 2017 | -18.48M |
| June 30, 2017 | -7.968M |
| March 31, 2017 | -20.96M |
| December 31, 2016 | -16.22M |
| September 30, 2016 | -14.69M |
| June 30, 2016 | -18.72M |
| March 31, 2016 | -11.82M |
| December 31, 2015 | -17.17M |
| September 30, 2015 | -1.179M |
| June 30, 2015 | -18.35M |
| March 31, 2015 | -17.98M |
| December 31, 2014 | -6.783M |
| September 30, 2014 | -6.890M |
| June 30, 2014 | -8.253M |
| March 31, 2014 | 8.82M |
Free Cash Flow Definition
Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.
Free Cash Flow (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow (Quarterly) Benchmarks
| Insmed, Inc. | -95.09M |
| Pfizer Inc. | 302.00M |
| Gossamer Bio, Inc. | -41.39M |
| Legend Biotech Corp. | -41.49M |
| Moderna, Inc. | -563.00M |